Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 4/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8986351 | 0.87 | BCHE (0.35) | MEN1KMT2ALMNANPC1RAB9A | |
| SCHEMBL14282584 | 0.87 | AKR1C3 (0.44) | MEN1KMT2AAKR1C3LMNAHTT | |
| SCHEMBL8986303 | 0.83 | LMNA (0.37) | MEN1KMT2AAKR1C3CNR1CNR2 | |
| SCHEMBL8986306 | 0.82 | AKR1C3 (0.40) | MEN1KMT2AAKR1C3LMNAHTT | |
| SCHEMBL13328292 | 0.80 | ALDH1A1 (0.47) | MEN1KMT2AAKR1C3LMNAHTT | |
| SCHEMBL11922326 | 0.80 | AKR1C3 (0.38) | MEN1KMT2AAKR1C3LMNAHTT | |
| SCHEMBL8986301 | 0.80 | AKR1C3 (0.38) | MEN1KMT2AAKR1C3LMNAHTT | |
| SCHEMBL13638717 | 0.80 | AKR1C3 (0.38) | MEN1KMT2AAKR1C3LMNAHTT | |
| SCHEMBL8986300 | 0.79 | AKR1C3 (0.38) | MEN1KMT2AAKR1C3LMNAHTT | |
| SCHEMBL13638716 | 0.77 | MAPT (0.32) | MEN1KMT2ALMNAPOLBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304561-B2 | Synthetic route to ABCD-porphyrins | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-11-06 | — | — | US | disclosed |
| US-20120209009-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-08-16 | — | — | US | disclosed |
| US-20120209009-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-08-16 | — | — | US | disclosed |
| US-8188298-B2 | Synthetic route to ABCD-porphyrins | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-05-29 | — | — | US | disclosed |
| US-8188298-B2 | Synthetic route to ABCD-porphyrins | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-05-29 | — | — | US | disclosed |
| US-20110306774-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-12-15 | — | — | US | disclosed |
| US-20110306774-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-12-15 | — | — | US | disclosed |
| US-7994312-B2 | Synthetic route to ABCD-porphyrins | NORTH CAROLINA STATE UNIVERSITY (US) | 2011-08-09 | — | — | US | disclosed |
| US-7994312-B2 | Synthetic route to ABCD-porphyrins | NORTH CAROLINA STATE UNIVERSITY (US) | 2011-08-09 | — | — | US | disclosed |
| US-20090082576-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | NORTH CAROLINA STATE UNIVERSITY (US) | 2009-03-26 | — | — | US | disclosed |
| US-20090082576-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | NORTH CAROLINA STATE UNIVERSITY (US) | 2009-03-26 | — | — | US | disclosed |
| WO-2008100461-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | NORTH CAROLINA STATE UNIVERSITY (US) | 2008-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120209009-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | ABCB7, ALAD, SLC39A14 | MEN1 3866/4885KMT2A 4227/4885AKR1C3 1386/4885 |
| US-20090082576-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | ABCB7, ALAD, SLC39A14 | MEN1 3866/4885KMT2A 4227/4885AKR1C3 1386/4885 |
| US-20110306774-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | ABCB7, ALAD, SLC39A14 | MEN1 3866/4885KMT2A 4227/4885AKR1C3 1386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.